TY  - ADVS
AU  - Shah,Dhaval K.
TI  - Modeling of antibody-drug conjugate pharmacokinetics
T2  - Periodic reports : advances in clinical interventions and research platforms,
PY  - 2019///
CY  - London
PB  - Henry Stewart Talks
KW  - Antibody-drug conjugates
KW  - Antineoplastic agents
KW  - Drug development
KW  - Antibodies, Monoclonal
KW  - pharmacokinetics
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Computer Simulation
KW  - Drug Design
KW  - Drug Discovery
KW  - methods
KW  - Immunoconjugates
KW  - pharmacology
KW  - Maytansine
KW  - Models, Biological
KW  - Trastuzumab
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Antibody drug conjugates (ADCs) and their uses -- Different ways to measure ADCs in the cell -- Typical ADC PK in cells -- Modeling the cellular PK of ADCs -- Modeling the tumor PK of ADCs -- 7 steps -- Modeling whole-body PK of ADCs -- Combining PK and PD models -- Kadcyla case study; Access restricted to subscribers
UR  - https://hstalks.com/bs/3983/
UR  - https://hstalks.com/bs/p/1048/
ER  -